HT
SRNE

HAP Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

HAP Trading’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-61,523
Closed -$382K – 2983
2021
Q3 		$469K Buy
61,523
+23,471
+62% +$199K 0.02% 700
2021
Q2 		$369K Sell
38,052
-16,406
-30% -$131K 0.01% 754
2021
Q1 		$450K Buy
+54,458
New +$575K 0.02% 521

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

HAP Trading's SRNE Position: Q4 2021 in Review

HAP Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 61,523 shares — an estimated $382K sold.

HAP Trading first reported a position in SRNE in Q1 2021 and held it in 3 quarters. The position peaked at $469K in Q3 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • HAP Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 61,523 Sorrento Therapeutics, Inc. shares in Q4 2021, an estimated $382K.
  • HAP Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and held it in 3 quarters.
  • HAP Trading's Sorrento Therapeutics, Inc. position peaked at $469K in Q3 2021.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.